Join our daily newsletter At The Bell to receive exclusive market insights
- Nuheara (NUH) appoints John Luna as its CEO to lead the company’s growing US-based hearing healthcare market opportunities
- Co-founder and former CEO, Justin Miller, will remain as Managing Director
- Meanwhile, the company also engaged Roth Capital Partners to explore US listing alternatives that support dual listings in Australia and the US
- Nuheara’s hearing device market presence in the US has been under development since the company’s inception, with a growing interest in the US following over-the-counter rule changes
- NUH shares last traded shares at one cent as of May 3
Nuheara (NUH) has appointed experienced medical device executive, John Luna as its CEO to lead the company’s growing US-based hearing healthcare market opportunities.
Mr Luna joined Nuheara in May 2021 and previously served as the Chief Revenue Officer and President Americas.
The incoming CEO has a proven track record of successfully leading companies and commercialising medical devices over a 30-year career, including launching the first 24/7 worn, subscription-based Lyric hearing device at InSound Medical.
John has previously served as CEO and COO of iHear Medical, Chief Business Development Officer of Eargo, and President and COO of Bernafon Demant.
Commenting on his appointment, Mr Luna said he is “honoured and excited” to capitalise on the momentum and opportunity entering the US over-the-counter, regulated, hearing aid market.
“We have been focused on enhancing our shareholder value and believe a listing on a major US exchange will help to broaden our investor shareholder base.
The company has also engaged Roth Capital Partners to explore US listing alternatives that support dual listings in Australia and the US.
“I’ve worked previously with Roth and know that their experience in medical devices along with their deep relationships with institutional investors in the US and globally will enhance this opportunity to explore a US listing and help us to deliver OTC hearing aids in the US,” said John Luna.
Commenting on the US based expansion, outgoing CEO and continuing Managing Director Justin Miller said this is “a very exciting and necessary step” for the company to solidify its presence in the US market.
“We have been pioneers in bringing accessibility and affordability into the hearing market globally, with no greater success being achieved for us than in the US.”
Nuheara’s hearing device market presence in the US has been under development since the company’s inception.
In building brand awareness with direct to consumer (DTC) and traditional retail sales partners, the US currently holds the majority of Nuheara’s global sales and growth.
With the new opportunities that are expected to be delivered because of the over-the-counter rule changes, it has resulted in a growing US investment bank interest in the company.
NUH shares last traded shares at one cent as of May 3.
